治疗心血管疾病药物使用情况的调查分析  

Investigation and Analysis on the Drug Use in the Treatment of Cardiovascular Disease

作　　者：旷吉琳 李莉[1] 朱丽萍[1] 陶孟瑶[2] 张婷[2] 高天[2] 

机构地区：[1]成都中医药大学,四川省成都市610075 [2]成都中医药大学附属医院

出　　处：《临床合理用药杂志》2014年第3期14-15,共2页Chinese Journal of Clinical Rational Drug Use

摘　　要：目的了解心血管疾病药物使用情况及其合理性。方法随机抽取我院2013年1—5月出院病历493份,以使用26种治疗心血管口服药的病历作为调查对象,占238份,对心血管疾病患者用药情况进行调查和分析,计算药物利用指数(DUI)。结果男性使用心血管药物的比例大;而各年龄段中,60岁以上的人使用心血管药的例数最多。使用频率较高的依次为阿司匹林、阿托伐他汀、厄贝沙坦、螺内酯、氯吡格雷。26种心血管口服药物中限定日剂量值(DDD)值较高的依次为胺碘酮、美西律、厄贝沙坦,氨氯地平、单硝酸异山梨酯、缬沙坦、辛伐他汀、氯吡格雷、阿司匹林DUI>1,其余20种药物的DUI≤1。结论绝大多数治疗心血管疾病的药物在临床应用上基本能做到合理用药。Objective To understand the use and rationality of the drugs for cardiovascular disease. Methods 493 hospital records in our hospital from January to May 2013 were randomly selected, among which 238 records used 26 kinds of cardiovascular oral medication, to investigate and analyze The medications in patients with cardiovascular disease were investigated and analyzed, than the drug utilization index （DUI） was calculated. Results The proportion of men use of cardiovascular drugs was large; And in all ages, people over the age of 60 using the maximum number of cases of cardiovascular drugs. Followed by the use of higher frequency of aspirin, atorvastatin, irbesartan, spironolactone, and clopidogrel. 26 kinds of cardiovascular oral drug limit daily dose （DDD） values were higher order to amiodarene, mexiletine, irbesartan; The DUI val- ue of amlodipine, isosorbide mononitrate, valsartan, simvastatin, clopidogrel, and aspirin were higher than 1, while the DUI value of the remaining 20 drugs were lower than 1. Conclusion The vast majority of the treatment of cardiovascular diseases can basically do rational drug use in clinical applications.

关 键 词：心血管疾病 药物制剂 数据收集 

分 类 号：R95[医药卫生—药学]